Log In To Your Account
Log In With Facebook
Posted: December 16th 2016 - Author: Bryce Sampson
The United States Drug Enforcement Administration (DEA) made an announcement on Wednesday that it amended the Schedule 1 Controlled Substances Act to include tighter regulations for marijuana extracts, including cannabidiol (CBD).
In the new drug code titled "Establishment of a New Drug Code for Marihuana Extract", the DEA says it is "creating a separate code number for marihuana extract with the following definition:
"Meaning an extract containing one ore more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crud or purified) obtained from the plant." Extracts of Marihuana will continue to be treated as Schedule I controlled substances.
In short, this means that all extracts from the cannabis plant (psychoactive or not) will come under Schedule I Drugs like heroin, LSD, marijuana, and ecstasy, and cannot cross state lines. Any person currently licensed to produce and handle marijuana extracts is required to apply for a modification of their registration by Jan. 13th, 2017.